Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00059644
Status:
TERMINATED
Last Update Posted:
2005-06-24
First Post:
2003-04-29
Brief Title:
EfficacySafety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
Sponsor:
Mitsubishi Tanabe Pharma Corporation
Organization:
Mitsubishi Tanabe Pharma Corporation
Organization Data
Organization:
Mitsubishi Tanabe Pharma Corporation
Class:
INDUSTRY
Study ID:
WFI 01-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mitsubishi Tanabe Pharma Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None